Gavriilaki, E.; Mallouri, D.; Bousiou, Z.; Demosthenous, C.; Vardi, A.; Dolgyras, P.; Batsis, I.; Stroggyli, E.; Karvouni, P.; Masmanidou, M.;
et al. Molecular and Clinical Characteristics of Different Toxicity Rates in Anti-CD19 Chimeric Antigen Receptor T Cells: Real-World Experience. Cancers 2023, 15, 4253.
https://doi.org/10.3390/cancers15174253
AMA Style
Gavriilaki E, Mallouri D, Bousiou Z, Demosthenous C, Vardi A, Dolgyras P, Batsis I, Stroggyli E, Karvouni P, Masmanidou M,
et al. Molecular and Clinical Characteristics of Different Toxicity Rates in Anti-CD19 Chimeric Antigen Receptor T Cells: Real-World Experience. Cancers. 2023; 15(17):4253.
https://doi.org/10.3390/cancers15174253
Chicago/Turabian Style
Gavriilaki, E., D. Mallouri, Z. Bousiou, C. Demosthenous, A. Vardi, P. Dolgyras, I. Batsis, E. Stroggyli, P. Karvouni, M. Masmanidou,
and et al. 2023. "Molecular and Clinical Characteristics of Different Toxicity Rates in Anti-CD19 Chimeric Antigen Receptor T Cells: Real-World Experience" Cancers 15, no. 17: 4253.
https://doi.org/10.3390/cancers15174253
APA Style
Gavriilaki, E., Mallouri, D., Bousiou, Z., Demosthenous, C., Vardi, A., Dolgyras, P., Batsis, I., Stroggyli, E., Karvouni, P., Masmanidou, M., Gavriilaki, M., Bouinta, A., Bitsianis, S., Kapravelos, N., Bitzani, M., Vasileiadou, G., Yannaki, E., Sotiropoulos, D., Papagiannopoulos, S.,
... Sakellari, I.
(2023). Molecular and Clinical Characteristics of Different Toxicity Rates in Anti-CD19 Chimeric Antigen Receptor T Cells: Real-World Experience. Cancers, 15(17), 4253.
https://doi.org/10.3390/cancers15174253
